ask="9.19"
ask_size="100"
average_daily_volume="309108"
bid="5.14"
bid_size="100"
book_value="1.77"
change="-0.17"
change_from_200_day_moving_average="0.05"
change_from_50_day_moving_average="-0.72"
change_from_52_week_high="-1.93"
change_From_52_week_low="2.14"
change_in_percent="-1.83%"
close="9.14"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.60"
ebitda="-135.66M"
eps_estimate_current_year="-1.67"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.36"
ex_dividend_date="N/A"
float_shares="14521000"
high="9.27"
high_52_weeks="11.07"
last_trade_date="3/14/2017"
last_trade_price="9.14"
last_trade_size="4957"
last_trade_time="4:00pm"
low="9.01"
low_52_weeks="7.00"
market_capitalization="167.26M"
moving_average_200_day="9.09"
moving_average_50_day="9.86"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="9.27"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.60%"
percent_change_from_50_day_moving_average="-7.28%"
percent_change_from_52_week_high="-17.43%"
percent_change_from_52_week_low="+30.57%"
previous_close="9.31"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.27"
price_per_sales="110.99"
revenue="1.53M"
shares_outstanding="18300000"
short_ratio="8.67"
stock_exchange="NGM"
symbol="AKBA"
volume="267462"
weeks_range_52="7.00 - 11.07"
